# Homi Bhabha National Institute

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/homi-bhabha-national-institute/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 45.5 |
| Citations | 925,149 |
| City | Mumbai |
| Country | IN |
| Description | Homi Bhabha National Institute is a research organisation in Mumbai, IN. OpenAlex records 24,363 works and 925,149 citations for it. 8,557 researchers list it as their most recent affiliation. |
| Homepage | http://www.hbni.ac.in/ |
| OpenAlex ID | https://openalex.org/I200207707 |
| Researchers | 8,557 |
| ROR ID | https://ror.org/02bv3zr67 |
| Type | education |
| Wikidata ID | https://www.wikidata.org/wiki/Q3532663 |
| Works | 24,363 |

## University papers

Showing 12 of 70.

- [The SCARE 2020 Guideline: Updating Consensus Surgical CAse REport (SCARE) Guidelines](https://scholariq.org/papers/the-scare-2020-guideline-updating-consensus-surgical-case-report-scare/)
- [The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After](https://scholariq.org/papers/the-2016-update-of-the-international-study-group-isgps-definition-and-grading-of/)
- [STROCSS 2021: Strengthening the reporting of cohort, cross-sectional and case-control studies in surgery](https://scholariq.org/papers/strocss-2021-strengthening-the-reporting-of-cohort-cross-sectional-and-case/)
- [STROCSS 2019 Guideline: Strengthening the reporting of cohort studies in surgery](https://scholariq.org/papers/strocss-2019-guideline-strengthening-the-reporting-of-cohort-studies-in-surgery/)
- [Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial](https://scholariq.org/papers/ramucirumab-plus-docetaxel-versus-placebo-plus-docetaxel-for-second-line/)
- [KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease](https://scholariq.org/papers/kdigo-2022-clinical-practice-guideline-for-diabetes-management-in-chronic-kidney/)
- [Nations within a nation: variations in epidemiological transition across the states of India, 1990–2016 in the Global Burden of Disease Study](https://scholariq.org/papers/nations-within-a-nation-variations-in-epidemiological-transition-across-the/)
- [The impact of air pollution on deaths, disease burden, and life expectancy across the states of India: the Global Burden of Disease Study 2017](https://scholariq.org/papers/the-impact-of-air-pollution-on-deaths-disease-burden-and-life-expectancy-across/)
- [The STROCSS statement: Strengthening the Reporting of Cohort Studies in Surgery](https://scholariq.org/papers/the-strocss-statement-strengthening-the-reporting-of-cohort-studies-in-surgery/)
- [The PROCESS 2020 Guideline: Updating Consensus Preferred Reporting Of CasE Series in Surgery (PROCESS) Guidelines](https://scholariq.org/papers/the-process-2020-guideline-updating-consensus-preferred-reporting-of-case-series/)
- [Health and economic impact of air pollution in the states of India: the Global Burden of Disease Study 2019](https://scholariq.org/papers/health-and-economic-impact-of-air-pollution-in-the-states-of-india-the-global/)
- [Metabolic non-communicable disease health report of India: the ICMR-INDIAB national cross-sectional study (ICMR-INDIAB-17)](https://scholariq.org/papers/metabolic-non-communicable-disease-health-report-of-india-the-icmr-indiab/)

## University researchers

- [Kumar Prabhash](https://scholariq.org/researchers/kumar-prabhash/)
- [Vanita Noronha](https://scholariq.org/researchers/vanita-noronha/)
- [Shaju K. Albert](https://scholariq.org/researchers/shaju-k-albert/)
- [Vijay Patil](https://scholariq.org/researchers/vijay-patil/)
- [N. Chandrasekhar](https://scholariq.org/researchers/n-chandrasekhar/)
- [Sridhar Sundaram](https://scholariq.org/researchers/sridhar-sundaram/)

## University top topics

Showing 8 of 24.

- [Particle physics theoretical and experimental studies](https://scholariq.org/topics/particle-physics-theoretical-and-experimental-studies/)
- [High-Energy Particle Collisions Research](https://scholariq.org/topics/high-energy-particle-collisions-research/)
- [Radioactive element chemistry and processing](https://scholariq.org/topics/radioactive-element-chemistry-and-processing/)
- [Quantum Chromodynamics and Particle Interactions](https://scholariq.org/topics/quantum-chromodynamics-and-particle-interactions/)
- [Nuclear Materials and Properties](https://scholariq.org/topics/nuclear-materials-and-properties/)
- [Nuclear reactor physics and engineering](https://scholariq.org/topics/nuclear-reactor-physics-and-engineering/)
- [Nuclear Physics and Applications](https://scholariq.org/topics/nuclear-physics-and-applications/)
- [Nuclear physics research studies](https://scholariq.org/topics/nuclear-physics-research-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.